Literature DB >> 15464582

At most three ES cells contribute to the somatic lineages of chimeric mice and of mice produced by ES-tetraploid complementation.

Zhongde Wang1, Rudolf Jaenisch.   

Abstract

Chimeric or entirely embryonic stem (ES) cell-derived mice ("ES mice") can be produced by injecting ES cells into diploid (2n) or tetraploid (4n) host blastocysts, respectively. Usually, between 10 and 15 ES cells are injected into the host blastocyst, but it is not clear how many of the injected cells contribute to the somatic lineages, thus serve as "founder cells" of the embryo proper. We have used genetically labeled ES cells to retrospectively determine the number of founder ES cells that generate the somatic lineages of chimeric and of ES mice. ES cell clones individually labeled with provirus were mixed in equal numbers and injected into 2n or 4n blastocysts to generate chimeric or ES mice. Southern analysis of DNA from the resulting animals indicated that the somatic lineages were most often derived from one or two and sometimes from up to three founder ES cells. The number of founder cells was independent of the total number of cells injected into the host blastocysts. Our results are consistent with the notion that constraints of the host embryo restrict the number of ES cells that can contribute to a chimeric or an ES mouse.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15464582     DOI: 10.1016/j.ydbio.2004.06.026

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  24 in total

1.  Production of mice using iPS cells and tetraploid complementation.

Authors:  Xiao-Yang Zhao; Zhuo Lv; Wei Li; Fanyi Zeng; Qi Zhou
Journal:  Nat Protoc       Date:  2010-04-29       Impact factor: 13.491

Review 2.  Hallmarks of pluripotency.

Authors:  Alejandro De Los Angeles; Francesco Ferrari; Ruibin Xi; Yuko Fujiwara; Nissim Benvenisty; Hongkui Deng; Konrad Hochedlinger; Rudolf Jaenisch; Soohyun Lee; Harry G Leitch; M William Lensch; Ernesto Lujan; Duanqing Pei; Janet Rossant; Marius Wernig; Peter J Park; George Q Daley
Journal:  Nature       Date:  2015-09-24       Impact factor: 49.962

3.  Production of chimeras by aggregation of embryonic stem cells with diploid or tetraploid mouse embryos.

Authors:  Guy S Eakin; Anna-Katerina Hadjantonakis
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

Review 4.  The molecular underpinnings of totipotency.

Authors:  Sophie M Morgani; Joshua M Brickman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-12-05       Impact factor: 6.237

Review 5.  The interplay of epigenetic marks during stem cell differentiation and development.

Authors:  Yaser Atlasi; Hendrik G Stunnenberg
Journal:  Nat Rev Genet       Date:  2017-08-14       Impact factor: 53.242

6.  Genome sequencing of mouse induced pluripotent stem cells reveals retroelement stability and infrequent DNA rearrangement during reprogramming.

Authors:  Aaron R Quinlan; Michael J Boland; Mitchell L Leibowitz; Svetlana Shumilina; Sidney M Pehrson; Kristin K Baldwin; Ira M Hall
Journal:  Cell Stem Cell       Date:  2011-10-04       Impact factor: 24.633

7.  Collective dynamics of stem cell populations.

Authors:  Ben D MacArthur
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-03       Impact factor: 11.205

8.  Developmental barcoding of whole mouse via homing CRISPR.

Authors:  Reza Kalhor; Kian Kalhor; Leo Mejia; Kathleen Leeper; Amanda Graveline; Prashant Mali; George M Church
Journal:  Science       Date:  2018-08-09       Impact factor: 47.728

9.  Functional heterogeneity of embryonic stem cells revealed through translational amplification of an early endodermal transcript.

Authors:  Maurice A Canham; Alexei A Sharov; Minoru S H Ko; Joshua M Brickman
Journal:  PLoS Biol       Date:  2010-05-25       Impact factor: 8.029

10.  Cytogenetic analysis and Dlk1-Dio3 locus epigenetic status of mouse embryonic stem cells during early passages.

Authors:  Aleksei Menzorov; Inna Pristyazhnyuk; Helen Kizilova; Anastasia Yunusova; Nariman Battulin; Antonina Zhelezova; Aleftina Golubitsa; Oleg Serov
Journal:  Cytotechnology       Date:  2014-06-27       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.